Skip to main content
. 2015 Jun 26;18(2):149–159. doi: 10.4048/jbc.2015.18.2.149

Table 2. Changes in distribution of the molecular types of breast cancers.

Surrogate definitions based on St. Gallen consensus
Before 2011 No. (%) St. Gallen 2011 No. (%) St. Gallen 2013 No. (%)
Luminal A type 149 (55.8) 76 (28.5) 58 (21.7)
Luminal B type 29 (10.9) 102 (38.2) 120 (44.9)
HER2 type 39 (14.6) 39 (14.6) 39 (14.6)
Triple-negative type* 50 (18.7) 50 (18.7) 50 (18.7)

HER2=human epidermal growth factor receptor 2.

*Including basal-like type.